Test Code 224
Test Details
Lipoprotein(a) (Lp(a))
Lp(a) is a plasma lipoprotein that is composed of two parts:
- LDL-like particle
- Apolipoprotein (a) [apo(a)], a protein made in the liver and attached to the apoB portion of this particle
Levels are determined by genetic factors.
Methodology
Immunoturbidimetric assay
Patient Preparation
None
Preferred Specimen
1.0 mL serum (0.5 mL minimum) collected in serum separator tube (SST/Tiger Top)
Alternate Specimen
- 1.0 mL EDTA plasma (0.5 mL minimum) collected in plasma separator tube (Pearl Top)
- Dried Blood collected on an AdvanceDx 100 card
Transport Temperature
Refrigerated (ship on frozen cold packs)
Stability
Refrigerated: 7 days
Lab Values
Lipoprotein(a) (Lp(a))
- Optimal: <30 mg/dL
- Borderline: 30–50 mg/dL
- High Risk: >50 mg/dL
Clinical Significance
Lipoprotein(a) (Lp(a))
Elevated levels are an independent risk factor for CVD.1-3
References:
- Nordestgaard BG, Chapman MJ, Ray K, et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J. 2010;31(23):2844–2853.
- Hoff HF, Beck GJ, Skibinski CI, et al. Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation. 1988;77(6):1238–1244.
- Lamon-Fava S, Marcovina SM, Albers JJ, Kennedy H, Deluca C, White CC, Cupples LA, McNamara JR, Seman LJ, Bongard V, Schaefer EJ. Lipoprotein(a) levels, isoforms, and coronary heart disease risk in the Framingham Off spring Study. J Lipid Res. 2011;52(6):1181-1187.
Treatment Options
Lipoprotein(a) (Lp(a))
- Niacin
- Optimize LDL-C, sdLDL-C and apoB
- Aspirin
